Lipolytic inhibitor G0S2 modulates glioma stem-like cell radiation response.
Yinfang WangYanli HouWeiwei ZhangAngel A AlvarezYongrui BaiBo HuShi-Yuan ChengKun YangYanxin LiHaizhong FengPublished in: Journal of experimental & clinical cancer research : CR (2019)
Our findings uncover a new function for lipolytic inhibitor G0S2 as an important regulator for GSC radioresistance, suggesting G0S2 as a potential therapeutic target for treating gliomas.